A new Olympus® assay for the determination of ceruloplasmin

Clinical Laboratory

Volumn 50, Issue 3-4, 2004, Pages 193-203

  Larkin, Tracey C ^a   Fingleton, Teresina A ^a   McCusker, Matthew ^a   Cassidy, Martin ^a   Gunzer, Gerhard ^a   Lepp, Cyrus A ^b   Gamboa, Erby ^b  

^a Olympus Diagnostica GmbH   (Ireland)

^b Olympus America   (United States)

Author keywords

Acute phase reactant; Ceruloplasmin; Olympus application; Turbidimetric method; Wilson's disease

Indexed keywords

ANTICOAGULANT AGENT; CERULOPLASMIN; EDETIC ACID; HEPARIN; LITHIUM; ORAL CONTRACEPTIVE AGENT;

ACCURACY; ANALYTIC METHOD; ANALYZER; ARTICLE; ASSAY; BLOOD SAMPLING; CALIBRATION; CERULOPLASMIN BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; DRUG USE; HEMOLYSIS; HODGKIN DISEASE; HUMAN; HYPERLIPIDEMIA; PREGNANCY; RETICULOENDOTHELIAL SYSTEM; STANDARDIZATION; TURBIDIMETRY; WILSON DISEASE; CHEMISTRY; EVALUATION; IMMUNOASSAY; INSTRUMENTATION; METHODOLOGY; PHOTOMETRY; REPRODUCIBILITY;

ANTICOAGULANTS; CERULOPLASMIN; HUMANS; IMMUNOASSAY; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS;

EID: 1842817732     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Johnson AM, Rohlfs EM Silverman LM. Proteins. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry. Philadelphia: WB Saunders Company, 1999; 4900-4922
2. Kazmierczak SC. Ceruloplasmin. In: Kaplan LA, Pesce AJ (eds) Clinical chemistry theory, analysis, correlation. St Louis: Mosby, 1996: 966
3. Tovey L.A.D., Lathe G.H. Ceruloplasmin and green plasma. Lancet, 1968: 2, 596-600
4. http://www.rochediagnostics.it/I_400plus/pdf/1998_Integra700_Protein.pdf
5. J.M.C. Gutteridge and J. Stocks. Caeruloplasmin: physiological and pathological perspectives. Crit Rev Clin Lab Sci 1981: 14: 257-329
6. Musci G; Bonaccorsi di Patti MC; Fagiolo U; Calabrese L. Age-related changes in human ceruloplasmin. Evidence for oxidative modifications. J Biol Chem 1993; Jun 25: 268 (18) 13388-95
7. Ryden L, Bjork I. Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry 1976; Aug 10: 15 (16) 3411-7
8. Winyard PG, Hider RC, Brailsford S, Drake AF, Lunec J, Blake DR. Effects of oxidative stress on some physiochemical properties of caeruloplasmin. Biochem J 1989; Mar 1: 258 (2) 435-45
9. Johnson AM, Rohlfs EM, Silverman LM. Proteins. In: Burtis CA, Ashwood ER (eds). Tietz textbook of clinical chemistry. WB Saunders Company, Philadelphia 1999: 492
10. NCCLS. Evaluation of the Linearity of Quantative Analytical Methods; Proposed Guideline - Second Edition. NCCLS document EP6-P2 (ISBN 1-56238-446-5) 2002; Vol 21; no 20
11. NCCLS. Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. NCCLS document EP5-A (ISBN 1-56238-368-X) 1999; Vol 19: no 2
12. NCCLS. User Demonstration of performance for Precision, and Accuracy; Proposed Guideline. NCCLS document EP15-P (ISBN 1-56328-366-3) 1998: Vol 18: no 22
13. NCCLS. Interference Testing in Clinical Chemistry; Proposed Guideline. NCCLS document EP7-P (ISSN 0273-3099) 1986; Vol 6: no 13
14. Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986; 32: 470-5
15. NCCLS. How to Define and Determine reference intervals in the Clinical Laboratory; Approved Guideline - Second Edition. NCCLS document C28-A2 (ISBN 1-56238-406-6) 2000; Vol 20
16. C Ricós, V Alvarez, F Cava, J V García-Lario, A Hernández, C V Jiménez, J Minchinela, C Perich, M Simón. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999; 59: 491-500
17. Clinical Guide to Laboratory Tests (3rd Edn). Norbert W. Tietz : 122
18. Baudner S, Dati F. Standardization of the measurement of 14 proteins in human serum based on the new IFCC/BCR/CAP international reference material CRM470. J Lab Med, 1996; 20: 145-152